As of Feb 26
| -3.91 / -2.18%|
The 15 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 200.00, with a high estimate of 225.00 and a low estimate of 150.00. The median estimate represents a +14.16% increase from the last price of 175.19.
The current consensus among 16 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.